Skip to content

Mindfulness, Optimism, and Resilience for Perinatal Health and Equity Study

Mindfulness, Optimism, and Resilience for Perinatal Health and Equity Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05840900
Acronym
MORPHE
Enrollment
100
Registered
2023-05-03
Start date
2024-02-20
Completion date
2026-10-01
Last updated
2025-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum Psychiatric Disorders

Keywords

dispositional optimism, mindfulness, adverse perinatal outcomes

Brief summary

Dispositional optimism (the general assumption that more good things than bad will occur across various life domains) has been tied to improved somatic and mental health outcomes. Dispositional optimism is malleable, although prior interventions have been time and resource intensive and thus are not well-tailored to the peripartum period. The purpose of this pilot study is to evaluate the feasibility and acceptability of a pregnancy-oriented mindfulness phone application (Expectful) versus standard care among first-time mothers with low dispositional optimism in early pregnancy. Other aims include evaluating the impact of Expectful use on dispositional optimism, adverse pregnancy outcomes (cesarean delivery, hypertensive disorders of pregnancy, and gestational diabetes) and postpartum post-traumatic stress symptoms.

Detailed description

This randomized clinical trial of nulliparous women with low dispositional optimism in early pregnancy seeks to determine whether use of a pregnancy-oriented digital mindfulness application will be feasible and acceptable and show preliminary evidence of efficacy in improving dispositional optimism, reducing adverse perinatal outcomes and improving postpartum post-traumatic stress symptoms. This pilot will include 100 women recruited from the obstetrical service at Women and Infants Hospital of Rhode Island. Women will be included if they are nulliparous, have a singleton pregnancy at \<20 weeks gestational age, speak English and have low dispositional optimism (a score of ≤14 on the validated, Revised Life Orientation Test). Eligible participants will be randomized to either using the digital app Expectful or standard pregnancy care. Women will be randomized with equal probability to the intervention group using block randomization stratified by race/ethnicity (Hispanic, non-Hispanic White/Other or non-Hispanic Black). Women in the mindfulness training arm will complete 8 weeks of daily mindfulness training exercises using Expectful. Women in the standard care group will receive standard pregnancy and postpartum care. Pregnancy and labor management will be at the discretion of each participant's obstetric provider. Participants in both groups will be asked to complete 4 questionnaires: one at enrollment, a post-intervention one at 8 weeks, at the time of delivery and at 6-8 weeks postpartum. Half of the participants in each arm (total n=50), will be asked to complete a qualitative, semi-structured interview on the role of optimism and other resilience factors in pregnancy.

Interventions

BEHAVIORALDigital Mindfulness Training

Once daily, 5-10 minute mindfulness exercises for 8 week intervention period using the existing perinatal mindfulness application Expectful

Sponsors

The Miriam Hospital
CollaboratorOTHER
Nina Ayala
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Participants and clinicians will not be blinded, but the outcomes assessor and analytic teams will be blinded to participant allocation.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Able to provide informed consent * English speaking * Nulliparous (no prior delivery at or greater than 20w0d gestation) * Pregnant with singleton fetus * \<20w0d gestation * Low dispositional optimism (score \</= 14 on the Revised Life Orientation Test) * Owns a smart phone

Exclusion criteria

* Plan to deliver at another institution * Ongoing (≥1/week) mind-body practice including mindfulness training, meditation or yoga * Pre-gestational hypertensive disorder * Pre-gestational diabetes mellitus

Design outcomes

Primary

MeasureTime frameDescription
Percentage of participants completing the assigned mindfulness exercises8-week intervention periodThe intervention will be considered feasible if ≥75% participants complete \>50% of the assigned daily mindfulness exercises over the 8-week intervention period
Intervention acceptabilityAfter 8 week intervention period, approximately 16-28 weeks gestation.The intervention will be considered acceptable if ≥75% report satisfied or very satisfied on a post-intervention consumer satisfaction survey with a 5-point Likert scale from very unsatisfied to very satisfied.

Secondary

MeasureTime frameDescription
Hypertensive disorder of pregnancy6-12 weeks postpartumBinary yes/no; includes gestational hypertension, pre-eclampsia with or without severe features, HELLP syndrome or eclampsia
Gestational diabetes mellitusDeliveryBinary yes/no
Dispositional optimismStudy enrollment and 6-12 weeks postpartumChange in dispositional optimism score (on validated Revised Life Orientation Test, scale range 0-24, higher scores indicate higher optimism) between enrollment and postpartum assessments
Traumatic birthDeliveryBinary yes/no; Self-reported experience of birth as traumatic given concern for life or well-being of self or infant
Postpartum post-traumatic stress symptoms6-12 weeks postpartumContinuous scale score using the PTSD Checklist for the Diagnostic and Statistical Manual of Mental Disorders (PCL-5, scale range 0-80, higher scores indicate worse post-traumatic stress symptoms)
Preterm birthDeliveryBinary yes/no; Delivery between 20w0d and 36w6d gestation
Cesarean deliveryDeliveryBinary yes/no

Countries

United States

Contacts

Primary ContactNina K Ayala, MD, MSCR
nayala@carene.org401-274-1100
Backup ContactEmily S Miller, MD, MPH
emmiller@carene.org401-274-1100

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026